Yitzchok Kurtzer
Internal Medicine · Scranton, PANPI 1154321891
Payments from drug & device makers
Across 1,459 payments — averaging $12.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- AbbVie$2K
- Novo Nordisk$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Boehringer Ingelheim$1K
- Johnson & Johnson$865
- plus $9K from 50 others
What the payments were for
- Food & beverage$18,23799%
- Education$2451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$1,534
- BREZTRI$969
- BEVESPI AEROSPHERE$589
- SYMBICORT$565
- BYDUREON$565
- MOVANTIK$312
- BREZTRI AEROSPHERE$253
- BRILINTA$253
- AIRSUPRA$248
How this compares
$18,482 in reported general payments places this provider in the 95th percentile of 5,705 internal medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 191 | $139,286 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 126 | $105,601 |
| FarxigaDapagliflozin Propanediol | 107 | $81,025 |
| MounjaroTirzepatide | 70 | $76,486 |
| OzempicSemaglutide | 65 | $70,441 |
| JardianceEmpagliflozin | 86 | $68,135 |
| JanuviaSitagliptin Phosphate | 58 | $55,109 |
| XareltoRivaroxaban | 61 | $47,497 |
| LinzessLinaclotide | 55 | $37,026 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 57 | $34,868 |
| RybelsusSemaglutide | 26 | $34,740 |
| TrulicityDulaglutide | 21 | $31,696 |
| MyrbetriqMirabegron | 57 | $31,100 |
| GlyxambiEmpagliflozin/Linagliptin | 33 | $30,119 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 32 | $24,021 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Premarin | $357 | $144,936202 claims |
| Boehringer IngelheimJardiance, Glyxambi, Trijardy Xr, Combivent Respimat | $1,170 | $131,160166 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $796 | $125,396172 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta | $3,106 | $121,606177 claims |
| Lilly USA, LLCMounjaro, Trulicity | $353 | $108,18291 claims |
| Novo NordiskOzempic, Rybelsus | $1,252 | $105,18191 claims |
| MerckJanuvia, Janumet Xr, Janumet, Belsomra | $545 | $98,912117 claims |
| Johnson & JohnsonXarelto, Invokana | $865 | $58,46481 claims |
| AbbVieLinzess, Vraylar | $1,796 | $55,51269 claims |
| Astellas Pharma US IncMyrbetriq | $337 | $31,10057 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $169 | $23,36037 claims |
| BayerKerendia | $733 | $19,35825 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,705 internal medicine providers in Pennsylvania.
Other internal medicine in Scranton
- Jonathan EpsteinPhiladelphia$13.1M
- Siddharth ShethPittsburgh$11M
- Nathan PatelTannersville$9.5M
- Pitamber DevgonPhiladelphia$7.5M
- Christopher StillDanville$7.1M
- Liza VillaruzPittsburgh$6.6M
- Paul HartleyUniontown$4.9M
- Victor KoladeSayre$4.7M
- Michael OliverBeaver$4.7M
- Raman PurighallaPittsburgh$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.